Amundi ETF Msci Germany UCITS ETF (CG1)

Hopefully we will live long enough to see it.

RLBY Happy 4th of July to all the longs here.

RLBY has moved from a distressed microcap story to one with real strategic optionality after the share retirement and operational improvements. The most probable direction is M&A exploration or a growth-oriented capital raise within the n

Just a feeling but imo it appears that they are creating a FIFA version of VuMe app. This would be a tremedous deal for FIFA and TPT (similar to MSG is for Yankees)

why is this stickied and the new data slides aren’t?

I was just thinking:

It is abundantly clear that this analysis (Dr. Bosch 03-07) and presentation has been a very important event.

Of course, you don't just 'give away' Advent to NWBO, which is what Linda Powers did on October 24, 2025.
This was so unexpected tha

Every time I go to sleep, i keep dreaming
we're gonna see a buck to the green tomorrow

That judge in Nevada didn’t see justice prevail so well for Amarin.

AI Summary
Nutranomics Inc. has ceased operations due to financial difficulties.
The company faced challenges in maintaining profitability and market competition.
Key products and services may no longer be available to consumers.
Employees were informed of layoffs and the

As far as finding you saying that specific quote, I will not find it. Thats something mainly found with Atlanta and I believe Madg. The part that says essentially derisk is me paraphrasing.

you guys warned me that Mgmt intended to use the public markets to essentially derisk the IP an

You're responding to an argument I didn't make. My comments were about the trial's methodology, endpoints, and more. If you disagree, you can start by explaining why the negative prespecified primary endpoint and the lack of a published randomised OS analysis don't matter, rather than telling me wha

dalton this week

https://www.youtube.com/watch?v=5QLj9AvceJ8

Gents, Now that APPLE is heavily invested in Credit Cards and Affinity Marketing, I wonder if they might one day enter the Fractional Shares space, taking on HOOD. It would be an Ace, my fund thinks. That is, a MONEY stock.

It was stated in one of the interviews "it works"

Points

www.msn.com/en-us/sports/moto_gp/how-one-single-nascar-cup-series-point-just-turned-into-50/ar-AA27fHDy?ocid=msedgntp&pc=W069&cvid=6a4a69669b1b4bdd935811a9192faa1b&ei=19 And the battle for the regular season championship

There was an r/s to bring the price to Nasdaq though. It went to like 3.00 and then it went all the way down to .30, and then there was an r/s to bring it back to 3. Then a year later it ran to 75 or whatever it was.

Even at a 8/1 ratio, that brings the OS under 1B.
.25 puts me on an endless beach under the stars, actually .10 does that too.

You sound increasingly like a paid pumper. Why are you twisting what was written? You keep editing and changing and shifting like scums that are posting here as employees of MMs. Are you being paid by NWBio to pump and keep retail investors hooked? I clearly said that the presentation is a non-ev

If you really believe all BP is against this company then your investment is doomed. But it might explain why management never ever made any open market purchases? 🤔🤷‍♀️

11, 19, 5, 23

Now July 7th, still no disclosed Lumb transactions

Hey Stephen, was you plot debunked before you even had a chance to disclose the details ?

We’re still waiting for your new hyped-up pipe dream…

https://investorshub.advfn.com/uimage/uploads/2020/11/22/vtz

Will an 8k filing be forthcoming?

He does very well on STAT which is where the true pros reside.

Opinions can be on both sides of the line. Its healthy and i respect it. Here in our case its biased. The shorts voicing here get BP or their HF sponsorship  as they will benefit if our technology dies in its tracks. Whereas the longs are supporting this company due to their conviction in its scienc

Don't forget to include Dr. P Kalinski work to ongoing HER2/HER3 breast cancer trial and P2 Ovarian cancer starting next month (August).
I think Dr. P Kalinski work will be focused on Women's cancer type.